Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
04/2003
04/03/2003WO2002081523A3 Method for preparing and selecting antibodies
04/03/2003WO2002078612A3 Thrombopoietin (tpo) synthebody for stimulation of platelet production
04/03/2003WO2002074925A3 Methods for identifying and purifying smooth muscle progenitor cells
04/03/2003WO2002074912A3 Tissue engineering enhanced by the transfer of a growth factor gene
04/03/2003WO2002070559A3 Nuclear hormone receptor ligand binding domains
04/03/2003WO2002068665A3 Constitutive promoter from arabidopsis
04/03/2003WO2002066649A3 ANTI-INTERFERON-α ANTIBODIES
04/03/2003WO2002059256A3 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
04/03/2003WO2002056753A3 P27 prevents cellular migration
04/03/2003WO2002042444A8 Fungal gene cluster associated with pathogenesis
04/03/2003WO2002033053A3 Method for enhancing primordial germ cell number
04/03/2003WO2002024909A9 Receptor nucleic acids and polypeptides
04/03/2003WO2002018544A9 Method and reagents for treatment of skin disorders by modulating the notch pathway
04/03/2003WO2002014526A3 Replication competent aav helper functions
04/03/2003WO2002014369A9 Human kininogen d5 domain polypeptides and their use
04/03/2003WO2002010214A3 Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same
04/03/2003WO2002000860A3 Novel proteases
04/03/2003WO2001072782A9 Immuno-reactive peptide ctl epitopes of human cytomegalovirus
04/03/2003US20030066103 Cytochrome P450 enzyme associated with the synthesis of delta12-epoxy groups in fatty acids of plants
04/03/2003US20030066102 Plant gene for p-hydroxyphenylpyruvate dioxygenase
04/03/2003US20030066100 Capacitative calcium entry mechanism in porcine oocytes
04/03/2003US20030066097 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer's Disease
04/03/2003US20030065159 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030065151 Secreted protein HCEJQ69
04/03/2003US20030065143 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030065142 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cancer and nervous system disorders
04/03/2003US20030065141 Polypeptide for use in the treatment of alzheimer's disease
04/03/2003US20030065137 Immunological methods to modulate myostatin in vertebrate subjects
04/03/2003US20030064944 Controlling cell differentiation, cell proliferation
04/03/2003US20030064925 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064923 Autoimmune disease; antiarthritic agents; genetic engineering
04/03/2003US20030064919 Novel polypeptides and polynucleotides encoding same
04/03/2003US20030064916 Antigen peptides; medical diagnosis
04/03/2003US20030064895 Jasmonic acid methyl ester mediating the defensive reactions upon invasion of phytopathogenic organisms and harmful insects; a plant growth regulator; gene encoding the enzyme; recombinant vector; transgenic plant; stress relieving
04/03/2003US20030064517 Expression vectors, transfection systems, and method of use thereof
04/03/2003US20030064513 Propagation and encapsulating preerential objects in culture; prepare nutrient broth, incoculate with encapaulated object, propagate in absence of gravity
04/03/2003US20030064512 Isolation of embryonic stem cells from animal embryos in vitro; prepare nutrient broth containing leukemia inhibitory factor, inoculate with cells, propagate, recover embryonic stem cells
04/03/2003US20030064511 Chondrocyte cells for use in the treatment of arthritic and bone disorders
04/03/2003US20030064510 Prevention or delaying apoptosis in recombinant cell; obtainceks transforme with nucleotide sequences coding antiapoptotic agents, express sequences, monitor adjustment in apotosis activity
04/03/2003US20030064503 Device
04/03/2003US20030064493 Methods and means for modulating PGE synthase activity
04/03/2003US20030064478 Nucleotide sequences coding polypeptide for use in the treatment and prevention parasitic infections
04/03/2003US20030064475 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins and uses thereof
04/03/2003US20030064473 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of tumors and cell proliferative disorders
04/03/2003US20030064470 Ligand for use as tool in the treatment of tumors in humans
04/03/2003US20030064469 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of tumors and cell proliferative disorders
04/03/2003US20030064468 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of tumors and cell proliferative disorders
04/03/2003US20030064467 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of tumors and cell proliferative disorders
04/03/2003US20030064466 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of tumors and cell proliferative disorders
04/03/2003US20030064465 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064464 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064463 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064462 Nucleotide sequences coding polypeptide for use in the treatment of tumor and cell proliferative disorders
04/03/2003US20030064461 Nucleotide sequences coding polypeptide for use in the treatment of tumor and cell proliferative disorders
04/03/2003US20030064460 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064459 Nucleotide sequences coding polypeptide for use in the treatment of tumor and cell proliferative disorders
04/03/2003US20030064458 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064457 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064456 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064455 Nucleotide sequences coding polypeptide for use in the treatment of tumor and cell proliferative disorders
04/03/2003US20030064454 Nucleotide sequences coding polypeptide for use in the treatment of tumor and cell proliferative disorders
04/03/2003US20030064453 Nucleotide sequences coding polypeptide for use in the treatment of tumor and cell proliferative disorders
04/03/2003US20030064452 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064451 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064450 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064449 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064448 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064447 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064446 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064445 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064444 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064443 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064442 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064431 Complement receptor type 1 (cr1)-like sequences
04/03/2003US20030064430 Novel steroid-activated nuclear receptors and uses therefor
04/03/2003US20030064426 Expression vector for use in the treatment of cancer and age-related defects
04/03/2003US20030064416 Diagnostic kit for use in diagnosis of alzheimer's disease
04/03/2003US20030064415 Propagation of cells; prepare nutrient broth, inoculate broth with cells, propagate cells, evaluate cells
04/03/2003US20030064413 Compositions and methods useful in avidity therapy
04/03/2003US20030064412 123 human secreted proteins
04/03/2003US20030064407 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064389 Isolating preferential antibodies; obtain sample containing antibody, incubate with antigen, incubate with modulator of antibody binding, recover antibody
04/03/2003US20030064383 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cancer
04/03/2003US20030064375 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of kidney, nervous system and arthritic disorders
04/03/2003US20030064369 Novel proteins and nucleic acids encoding same
04/03/2003US20030064367 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064358 Screening modulators of contractile force and tissue stiffness in cells; obtain cells, incubate with modulator, monitor contractile activity and stiffness in cells
04/03/2003US20030064119 Methods and compositions for applying essential oils and naturally occurring compounds to plants to activate endogenous plant pathogen defense pathways
04/03/2003US20030064089 Regenerated cellulose and oxidized cellulose membranes as potential biodegradable platforms for drug delivery and tissue engineering
04/03/2003US20030064082 Administering an antipsychotic agent to the individual in such a manner as to increase neurogenesis by a predetermined amount in at least one region of the brain
04/03/2003US20030064080 Administering hapten modified syngeneic human tumor cell substantially in a no growth phase and an adjuvant for therapy of cancer
04/03/2003US20030064074 Recombinant gelatins in vaccines
04/03/2003US20030064068 Antithrombotic agent and humanized anti-von willebrand factor monoclonal antibody
04/03/2003US20030064067 Inducing differentiation and/or promoting proliferation of regulatory T cells, comprising allowing a CD3 agonist and a 4C8 antigen agonist to act on an immunocyte expressing CD3 and 4C8 antigens
04/03/2003US20030064065 35 kappaD tumor associated protein antigen: uses and methods detection
04/03/2003US20030064063 For prophylaxis of type I hypersensitivity disease in a subject receiving immunotherapy
04/03/2003US20030064062 For use in pharmaceuticals, diagnostics, biosensors and bioreactors
04/03/2003US20030064059 Embryonic stem cells, clinical applications and methods for expanding in vitro
04/03/2003US20030064058 Methods of utilizing bone marrow stem cells for inducing immunological tolerance
04/03/2003US20030064057 Administering hematopoietic stem cells to the patient via intravenous injection; administering neuronal stem cells to the patient via subcutaneous injection for improving athletic performance and increasing lean muscle mass in a patient